Special thanks to our friends at Ambience Healthcare, who have made this post free to all users as part of sponsoring Second Opinion.

Ambience Healthcare is the leading AI platform for clinical documentation and coding—trusted by top health systems like Cleveland Clinic, UCSF Health, St. Luke’s Health System, and Houston Methodist.

In partnership with KLAS Research and St. Luke’s Health System, Ambience also just published a breakthrough impact report, detailing how St. Luke’s is leveraging Ambience’s AI platform to reduce documentation time and clinician burnout, while improving documentation accuracy and revenue integrity (generating more than $13K annually per clinician). 

Longevity is a booming category of healthcare, and the companies in the space are gaining traction. But it still elicits mixed reviews from clinicians, given the lack of studies to backup the approach. Some believe it’s mostly an intervention for the so-called “worried well,” who are willing to pay to optimize their health, despite being generally healthy. Others view it as a fresh spin on primary care and prevention, one that patients are willing to pay for out-of-pocket — and therefore worthy of greater exploration and even investment. I tend to take a broader view, and believe that longevity investments are critical to a world in crisis with rising rates of chronic disease and a population that is getting older and sicker.

Healthcare investors are seeing potential too, particularly given the rapid growth that companies like Function Health, Superpower and Lifeforce have seen. But how do firms view the opportunity here, now that some of the big bets have been made? Function Health is already valued at $2.5 billion, as of February of this year. And Superpower just raised $30 million. Given that, where are firms looking to make investments going forward?

7wireVentures, based in Chicago, has been digging into the space over the past few years, culminating in a deck shared with its own limited partners about the longevity market. The firm agreed to share the full presentation with Second Opinion readers exclusively, in the hopes that it would inform all of our collective thinking and provoke some interesting discussion. Download the full deck below.

Please join our mailing list to keep reading

Much of our content is free, but to see it all you have to subscribe to Second Opinion.

Already a subscriber?Sign in.Not now

Reply

or to participate

Keep Reading

No posts found